Effect of Additive Lorazepam on Patient Satisfaction as a Premedication in Diagnostic Flexible Bronchoscopy

Overview[ - collapse ][ - ]

Purpose Many patients undergoing flexible bronchoscopy (FB) experience anxiety and discomfort during the procedure. The investigators want to evaluate whether an additional Lorazepam premedication would improve patient satisfaction for FB.
ConditionPatient Satisfaction for Bronchoscopy
InterventionDrug: Lorazepam
Drug: Control
PhasePhase 4
SponsorSeoul National University Hospital
Responsible PartySeoul National University Hospital
ClinicalTrials.gov IdentifierNCT01121055
First ReceivedMay 9, 2010
Last UpdatedMay 27, 2010
Last verifiedMay 2010

Tracking Information[ + expand ][ + ]

First Received DateMay 9, 2010
Last Updated DateMay 27, 2010
Start DateMarch 2010
Estimated Primary Completion DateDecember 2010
Current Primary Outcome Measurespatient satisfaction [Time Frame: within 24 hr of bronchoscopy] [Designated as safety issue: Yes]
Current Secondary Outcome Measuresrelationship between patient satisfaction and sleep quality, anxiety level [Time Frame: 24hr before and after bronchoscopy] [Designated as safety issue: Yes]

Descriptive Information[ + expand ][ + ]

Brief TitleEffect of Additive Lorazepam on Patient Satisfaction as a Premedication in Diagnostic Flexible Bronchoscopy
Official TitleEffect of Additive Lorazepam on Patient Satisfaction as a Premedication in Diagnostic Flexible Bronchoscopy
Brief Summary
Many patients undergoing flexible bronchoscopy (FB) experience anxiety and discomfort during
the procedure. The investigators want to evaluate whether an additional Lorazepam
premedication would improve patient satisfaction for FB.
Detailed Description
The enrolled patients are randomized to either the control or Lorazepam groups according to
a random sample chart of numbers. The patients complete questionnaires about baseline
anxiety level and satisfaction for FB within 24 hours after the FB.
Study TypeInterventional
Study PhasePhase 4
Study DesignAllocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Supportive Care
ConditionPatient Satisfaction for Bronchoscopy
InterventionDrug: Lorazepam
Lorazepam 0.5mg po at night one day before FB and Lorazepam 1mg po 30min before the FB
Drug: Control
Placebo 1T po at night one day before FB and placebo 1T po 30min before the FB
Study Arm (s)
  • Placebo Comparator: Control
    Placebo 1T by mouth (po) at night one day before FB and placebo 1T po 30min before the FB
  • Experimental: Lorazepam
    Lorazepam 0.5mg po at night one day before FB and Lorazepam 1mg po 30min before the FB

Recruitment Information[ + expand ][ + ]

Recruitment StatusRecruiting
Estimated Enrollment372
Estimated Completion DateDecember 2010
Estimated Primary Completion DateAugust 2010
Eligibility Criteria
Inclusion Criteria:

- Adult patients (aged 18 years or older) admitted to the Respiratory Department

Exclusion Criteria:

- outpatient procedures

- therapeutic bronchoscopy

- expected operation or discharge within 24 hours after the FB

- sedative premedication

- endotracheal intubation with mechanical ventilation

- inability to speak Korean
GenderBoth
Ages18 Years
Accepts Healthy VolunteersNo
ContactsContact: Seok-Chul Yang, MD, PhD
+82-2-2072-0354
scyang@snu.ac.kr
Location CountriesKorea, Republic of

Administrative Information[ + expand ][ + ]

NCT Number NCT01121055
Other Study ID NumbersLorazepam in FB
Has Data Monitoring CommitteeYes
Information Provided BySeoul National University Hospital
Study SponsorSeoul National University Hospital
CollaboratorsNot Provided
Investigators Study Chair: Seok-Chul Yang, MD Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine and Lung Institute of Medical Research Center, Seoul National University College of Medicine
Verification DateMay 2010

Locations[ + expand ][ + ]

Seoul National University Hospital
Seoul, Korea, Republic of, 110-744
Contact: Seok-Chul Yang, MD | scyang@snu.ac.kr
Recruiting